Celgene Corporation (Nasdaq: CELG) to Ring The Nasdaq Stock Market Closing Bell
September 08 2016 - 10:00AM
What: Celgene Corporation
(Nasdaq:CELG), an integrated global biopharmaceutical company, will
visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Mark J. Alles,
Chief Executive Officer, will ring the Closing
Bell.
Where:Nasdaq MarketSite – 4 Times
Square – 43rd & Broadway – Broadcast Studio
When:Friday, September 9, 2016 –
3:45 p.m. to 4:00 p.m. ET
Celgene Media Contact:Brian
Gill(908) 673-9530bgill@celgene.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line
(Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast:A live stream of the Nasdaq Closing
Bell will be available
at: https://new.livestream.com/nasdaq/live or
http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution
photograph of the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About CelgeneCelgene Corporation, headquartered
in Summit, New Jersey, is an integrated global
biopharmaceutical company engaged primarily in the discovery,
development and commercialization of innovative therapies for the
treatment of cancer and inflammatory diseases through
next-generation solutions in protein homeostasis, immuno-oncology,
epigenetics, immunology and neuro-inflammation. For more
information, please visit www.celgene.com.
Follow Celgene on Social Media: @Celgene, Pinterest,
LinkedIn, Facebook and YouTube.
About Nasdaq-100 Index®The Nasdaq-100 Index,
launched in January 1985, is one of the most widely followed
benchmarks in the world. The Nasdaq-100 Index is the basis of the
PowerShares QQQ Trust (Nasdaq:QQQ) which aims to provide investment
results that, before expenses, correspond with the NASDAQ-100
Index's performance. In addition, options, futures and structured
products based on the Nasdaq-100 Index and the PowerShares QQQ
Trust trade on various exchanges.
About NasdaqNasdaq (Nasdaq:NDAQ) is a leading
provider of trading, clearing, exchange technology, listing,
information and public company services across six continents.
Through its diverse portfolio of solutions, Nasdaq enables
customers to plan, optimize and execute their business vision with
confidence, using proven technologies that provide transparency and
insight for navigating today's global capital markets. As the
creator of the world's first electronic stock market, its
technology powers more than 70 marketplaces in 50 countries, and 1
in 10 of the world's securities transactions. Nasdaq is home to
more than 3,700 listed companies with a market value of
approximately $9.3 trillion and nearly 18,000 corporate clients. To
learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
-NDAQA-
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Sep 2023 to Sep 2024